Association of NAD(P)H: Quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population

Carcinogenesis

Volumn 24, Issue 5, 2003, Pages 905-909

  Zhang, Jianhui ^a,b   Schulz, Wolfgang A ^a   Li, Yan ^b   Wang, Rui ^b   Zotz, Rainer ^a   Wen, Denggui ^b   Siegel, David ^c   Ross, David ^c   Gabbert, Helmut E ^a   Sarbia, Mario ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CARCINOGEN; CYTOSINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); THYMINE;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CAUCASIAN; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; DETOXIFICATION; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CARCINOMA; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GERMANY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UPPER GASTROINTESTINAL TRACT;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; DNA; DNA PRIMERS; ESOPHAGEAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RISK FACTORS;

EID: 12444342653     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg019     Document Type: Article

References (28)

1. Pisani,P., Parkin,M., Bray,F. and Ferlay, J. (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18-29.
2. Devesa,S.S., Blot,W.J. and Fraumeni, J.F.J. (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer, 83, 2049-2053.
3. Launoy,G., Milan,C.H., Faivre, J., Pienkowski,P., Milan,C.I. and Gignoux,M. (1997) Alcohol, tobacco and oesophageal cancer: effects of the duration of consumption, mean intake and current and former consumption. Br. J. Cancer, 75, 1389-1396.
4. Yang,C.S. (2000) Vitamin nutrition and gastroesophageal cancer. J. Nutr., 130,338S-339S
5. Ghadirian,P., Vobecky,J. and Vobecky,J.S. (1988) Factors associated with cancer of the oesophagus: an overview. Cancer Detect. Prev., 11, 225-234
6. Yokokawa,Y., Ohta,S., Hou,J., Zhang,X.L., Li,S.S., Ping,Y.M. and Nakajima,T. (1999) Ecological study on the risks of esophageal cancer in Ci-Xian, China: the importance of nutritional status and the use of well water. Int. J. Cancer, 83, 620-624
7. Hu,N., Dawsey,S.M., Wu,M., Bonney,G.E., He,L.J., Han,X.Y., Fu,M. and Taylor,P.R. (1992) Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China. Int. J. Epidemiol., 21, 877-882.
8. Chang-Claude,J., Becher,H., Blettner,M., Qiu,S., Yang,G. and Wahrendorf,J. (1997) Familial aggregation of oesophageal cancer in a high incidence area in China. Int. J. Epidemiol., 26, 1159-1165
9. Guengerich,F.P. (1992) Metabolic activation of carcinogens. Pharmacol. Ther., 54, 17-61
10. Matsuo,K., Hamajima,N., Shinoda,M., Hatooka,S., Inoue,M., Takezaki,T. and Tajima,K. (2001) Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis, 22, 913-916.
11. Song,C., Xing,D., Tan,W., Wei,Q. and Lin,D. (2001) Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res., 61, 3272-3275.
12. Tan,W., Song,N., Wang,G.Q., Liu,Q., Tang,H.J., Kadlubar,F.F. and Lin,D.X. (2000) Impact of genetic polymorphisms in cytochrome P450 2EI and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol. Biomark. Prev., 9, 551-556.
13. Rauth,A.M., Goldberg,Z. and Misra,V. (1997) DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis. Oncol. Res., 9, 339-349.
14. Kuehl,B.L., Paterson,J.W., Peacock,J.W., Paterson,M.C. and Rauth,A.M. (1995) Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br. J. Cancer, 72, 555-561.
15. Moran,J.L., Siegel,D. and Ross,D. (1999) A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc. Natl Acad. Sci. USA, 96, 8150-8155.
16. Siegel,D., Anwar,A., Winski,S.L., Kepa,J.K., Dowd,K.L. and Ross,D. (2001) Rapid polyubiquination and proteasomal degradation of a mutant form of NAD(P)H: quinone oxidoreductase 1. Mol. Pharmacol., 59, 263-268.
17. Gaedigk,A., Tyndale,R.F., Jurima-Romet,M., Sellers,E.M., Grant,D.M. and Leeder,J.S. (1998) NAD(P)H: quinone oxidoreductase polymorphisms and allele frequencies in Caucasians, Chinese and Canadian Native Indian and Inuit populations. Pharmacogenetics, 8, 305-313.
18. Schulz,W.A., Krummeck,A., Rösinger,I., Eickelmann,P., Neuhaus,C., Ebert,T., Schmitz-Dräger,B.J. and Sies,H. (1997) Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics, 7, 235-239.
19. Wiemels,J.L., Pagnamenta,A., Taylor,G.M., Eden,O.B., Alexander,F.E. and Greaves,M.F., United Kingdom Childhood Cancer Study Investigators. (1999) A lack of a functional NAD(P)H: quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. Cancer Res., 59, 4095-4099.
20. 609C → T polymorphism in the NAD(P)H: quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood, 94, 803-807.
21. Rosvold,E.A., McGlynn,K.A., Lustbader,E.D. and Buetow,K.H. (1995) Identification of an NAD(P)H: quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics, 5, 199-206.
22. Chen,H., Lum,A., Seifried,A., Wilkens,L.R. and Marchand,L.L. (1999) Association of the NAD(P)H: quinone oxidoreductase 609C → T polymorphism with a decreased lung cancer risk. Cancer Res., 59, 3045-3048.
23. Eickelmann,P., Schulz,W.A., Rohde,D., Schmitz-Dräger,B. and Sies,H. (1994) Loss of heterozygosity at the NAD(P)H: quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. Biol. Chem. Hoppe-Seyler, 375, 439-445.
24. Miller,S.A., Dybes,D.D. and Polesky,H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res., 16, 1215.
25. Siegel,D., Franklin,W.A. and Ross,D. (1998) Immunohistochemical detection of NAD(P)H: quinone oxidoreductase in human lung and lung tumors. Clin. Cancer Res., 4, 2065-2070.
26. Siegel,D. and Ross,D.(2000) Immunodetection of NAD(P)H: quinone oxidoreductase 1 (NQO1) in human tissues. Free. Rad. Biol. Med., 29, 246-253.
27. Clairmont,A., Sies,H., Ramachandran,S., Lear,J.T., Smith,A.G., Bowers,B., Jones,P.W., Fryer,A.A. and Strange,R.C. (1999) Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. Carcinogenesis, 20, 1235-1240.
28. Zhang,W., Bailey-Wilson,J., Li,W., Wang,X., Zhang,C., Mao,X., Liu,Z., Zhou,C. and Wu,M. (2000) Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China. Am. J. Hum. Genet., 67, 110-119.